Wnt signaling in triple-negative breast cancer

Sö G. Pohl; N. Brook; M. Agostino; F. Arfuso; A. P. Kumar; A. Dharmarajan

doi:10.1038/oncsis.2017.14

Wnt signaling in triple-negative breast cancer

Sö G. Pohl
, N. Brook
, M. Agostino
, F. Arfuso
, A. P. Kumar
, A. Dharmarajan

Research output: Contribution to journal › Review article › peer-review

249 Citations (Scopus)

Abstract

Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.

Original language	English
Article number	e310
Journal	Oncogenesis
Volume	6
Issue number	4
DOIs	https://doi.org/10.1038/oncsis.2017.14
Publication status	Published - 3 Apr 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/oncsis.2017.14Licence: CC BY

Cite this

@article{1fbd07e8dd004e269f5b80a3f7539b1f,

title = "Wnt signaling in triple-negative breast cancer",

abstract = "Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.",

author = "Pohl, \{S{\"o} G.\} and N. Brook and M. Agostino and F. Arfuso and Kumar, \{A. P.\} and A. Dharmarajan",

note = "Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2017",

month = apr,

day = "3",

doi = "10.1038/oncsis.2017.14",

language = "English",

volume = "6",

journal = "Oncogenesis",

issn = "2157-9024",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Wnt signaling in triple-negative breast cancer

AU - Pohl, Sö G.

AU - Brook, N.

AU - Agostino, M.

AU - Arfuso, F.

AU - Kumar, A. P.

AU - Dharmarajan, A.

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.

AB - Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.

UR - https://www.scopus.com/pages/publications/85016934868

U2 - 10.1038/oncsis.2017.14

DO - 10.1038/oncsis.2017.14

M3 - Review article

AN - SCOPUS:85016934868

SN - 2157-9024

VL - 6

JO - Oncogenesis

JF - Oncogenesis

IS - 4

M1 - e310

ER -

Wnt signaling in triple-negative breast cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this